IP Library › Granted Patent US 8,648,085
Granted Patent B2
US 8,648,085 · App. 12/744,750 · Granted Feb 11, 2014

1, 5-dihydro-pyrazolo (3, 4-D) pyrimidin-4-one derivatives and their use as PDE9A mudulators for the treatment of CNS disorders

Inventors: Christian Eickmeier (Mittelbiberach, DE); Cornelia Dorner-Ciossek (Warthausen, DE); Dennis Fiegen (Biberach, DE); Thomas Fox (Biberach, DE); Klaus Fuchs (Mittelbiberach, DE); Riccardo Giovannini (Verona, IT); Niklas Heine (Biberach, DE); Martin Hendrix (Orinda, CA); Holger Rosenbrock (Mittelbiberach, DE); Gerhard Schaenzle (Biberach, DE)
Assignee: Boehringer Ingelheim International GmbH
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,648,085
App. No.
12/744,750
Granted
Feb 11, 2014
Kind
B2
Abstract

The invention relates to novel substituted pyrazolopyrimidines. Chemically, the compounds are characterized by general Formula (I): with R 1 being phenyl or pyridyl, any of which is substituted with 1 to 4, preferably 1 to 3 substituents X; X independently of each other being selected from C 2 -C 6 -alky 1 or Ci-C 6 -alkoxy, where C 2 -C 6 -alkyl and C 1 -C 6 -alkoxy are at least dihalogenated up to perhalogenated. preferably with 2 to 6 halogen substituents, and the halogen atoms being selected from the group of fluoro, chloro and bromo, preferably fluoro; R 2 being phenyl or heteroaryl, where phenyl is substituted by 1 to 3 radicals and heteroaryl is optionally substituted by 1 to 3 radicals in each case independently of one another selected from the group of C 1 -C 6 -alkyl, C 1 -C 6 -alkoxy, hydroxycarbonyl, cyano, trifluoromethyl, amino, nitro, hydroxy, C 1 -C 6 -alkylamino, halogen, C 6 -C 10 -arylcarbonylamino, C 1 -C 6 -alkylcarbonylamino, C 1 -C 6 -alkylaminocarbonyl. C 1 -C 6 -alkoxycarbonyl, C 6 -C 10 -arylaminocarbonyl, heteroarylaminocarbonyl. heteroarylcarbonylamino, C 1 -C 6 -alkylsulphonyl-amino, C 1 -C 6 -alkylsulphonyl and C 1 -C 6 -alkylthio; The new compounds shall be used for the manufacture of medicaments, in particular medicaments for improving, perception, concentration, learning and/or memory in patients in need thereof.

Claims (91)

1. A compound of formula I:

with

R 1

being phenyl or pyridyl, any of which is substituted with 1 to 4 substituents X;

and with the option that each of phenyl or pyridyl in addition may be substituted by up to 3 radicals independently of one another selected from the group of C 1 -C 6 -alkyl, C 1 -C 6 -alkoxy, hydroxycarbonyl, cyano, trifluoromethyl, amino, nitro, hydroxy, C 1 -C 6 -alkylamino, halogen, C 6 -C 10 -arylcarbonylamino, C 1 -C 6 -alkylcarbonylamino, C 1 -C 6 -alkylaminocarbonyl, C 1 -C 6 -alkoxycarbonyl, C 6 -C 10 -arylaminocarbonyl, heteroarylamino-carbonyl, heteroarylcarbonylamino, C 1 -C 6 -alkylsulphonylamino, C 1 -C 6 -alkylsulphonyl, or C 1 -C 6 -alkylthio,

where each of C 1 -C 6 -alkyl, C 1 -C 6 -alkoxy, C 1 -C 6 -alkylamino, C 6 -C 10 -arylcarbonylamino, C 1 -C 6 -alkylcarbonylamino, C 1 -C 6 -alkylaminocarbonyl, C 1 -C 6 -alkoxycarbonyl, C 6 -C 10 -arylaminocarbonyl, heteroarylaminocarbonyl, heteroarylcarbonylamino, C 1 -C 6 -alkylsulphonylamino, C 1 -C 6 -alkylsulphonyl and C 1 -C 6 -alkylthio are optionally substituted by 1 to 3 radicals independently of one another selected from the group of hydroxy, cyano, halogen, hydroxycarbonyl and a group of the formula —NR 3 R 4 ,

X

independently of each other being selected from C 1 -C 6 -alkoxy, where the C 1 -C 6 -alkoxy is substituted with 2 to 6 halogen substituents, and the halogen substituents are selected from the group of fluoro, chloro and bromo, whereby the C-atom directly attached to the O-atom, which constitutes the beta position with respect to the link to the phenyl or pyridyl, is substituted with at least one halogen atom;

R 2

being phenyl or heteroaryl, where phenyl is substituted by 1 to 3 radicals and heteroaryl is optionally substituted by 1 to 3 radicals in each case independently of one another selected from the group of C 1 -C 6 -alkyl, C 1 -C 6 -alkoxy, hydroxycarbonyl, cyano, trifluoromethyl, amino, nitro, hydroxy, C 1 -C 6 -alkylamino, halogen, C 6 -C 10 -arylcarbonylamino, C 1 -C 6 -alkylcarbonylamino, C 1 -C 6 -alkylaminocarbonyl, C 1 -C 6 -alkoxycarbonyl, C 6 -C 10 -arylaminocarbonyl, heteroarylaminocarbonyl, heteroarylcarbonylamino, C 1 -C 6 -alkylsulphonylamino, C 1 -C 6 -alkylsulphonyl and C 1 -C 6 -alkylthio,

where each of C 1 -C 6 -alkyl, C 1 -C 6 -alkoxy, C 1 -C 6 -alkylamino, C 6 -C 10 -arylcarbonylamino, C 1 -C 6 -alkylcarbonylamino, C 1 -C 6 -alkylaminocarbonyl, C 1 -C 6 -alkoxycarbonyl, C 6 -C 10 -arylaminocarbonyl, heteroarylaminocarbonyl, heteroarylcarbonylamino, C 1 -C 6 -alkylsulphonylamino, C 1 -C 6 -alkylsulphonyl and C 1 -C 6 -alkylthio are optionally substituted by one to three radicals independently of one another selected from the group of hydroxy, cyano, halogen, hydroxycarbonyl and a group of the formula —NR 3 R 4 ,

R 3

being hydrogen or C 1 -C 6 -alkyl,

and R 4

being hydrogen or C 1 -C 6 -alkyl,

or R 3 and R 4 together with the nitrogen atom to which they are bonded are 5- to 8-membered heterocyclyl.

2. A compound according to claim 1 , characterized in that

R 1

being phenyl or pyridyl, any of which is substituted with 1 to 3 substituents X;

and with the option that each of phenyl or pyridyl in addition may be substituted by up to 3 radicals independently of one another selected from the group of C 1 -C 6 -alkyl, C 1 -C 6 -alkoxy, cyano, trifluoromethyl, nitro, halogen, C 6 -C 10 -arylcarbonylamino, C 1 -C 6 -alkyl-carbonylamino, C 1 -C 6 -alkylaminocarbonyl, C 6 -C 10 -arylaminocarbonyl, heteroarylamino-carbonyl, heteroarylcarbonylamino, C 1 -C 6 -alkylsulphonylamino, C 1 -C 6 -alkylsulphonyl, or C 1 -C 6 -alkylthio,

where each of C 1 -C 6 -alkyl, C 1 -C 6 -alkoxy, C 6 -C 10 -arylcarbonylamino, C 1 -C 6 -alkyl-carbonylamino, C 1 -C 6 -alkylaminocarbonyl, C 6 -C 10 -arylaminocarbonyl, heteroarylamino-carbonyl, heteroarylcarbonylamino, C 1 -C 6 -alkylsulphonylamino, C 1 -C 6 -alkylsulphonyl and C 1 -C 6 -alkylthio are optionally substituted by one to three radicals independently of one another selected from the group of hydroxy, cyano, halogen, and a group of the formula —NR 3 R 4 ,

R 2

being phenyl or heteroaryl, where phenyl is substituted by 1 to 3 radicals and heteroaryl is optionally substituted by 1 to 3 radicals in each case independently of one another selected from the group of C 1 -C 6 -alkyl, C 1 -C 6 -alkoxy, hydroxycarbonyl, cyano, trifluoromethyl, amino, nitro, hydroxy, C 1 -C 6 -alkylamino, halogen, C 1 -C 6 -alkyl-carbonylamino, C 1 -C 6 -alkylaminocarbonyl, C 1 -C 6 -alkylsulphonylamino, C 1 -C 6 -alkyl-sulphonyl and C 1 -C 6 -alkylthio,

where each of C 1 -C 6 -alkyl, C 1 -C 6 -alkoxy, C 1 -C 6 -alkylamino, C 1 -C 6 -alkylcarbonylamino, C 1 -C 6 -alkylaminocarbonyl, C 1 -C 6 -alkylsulphonylamino, C 1 -C 6 -alkylsulphonyl and C 1 -C 6 -alkylthio are optionally substituted by one to three radicals independently of one another selected from the group of hydroxy, cyano, halogen, and a group of the formula —NR 3 R 4 ,

and the remaining characteristics as defined in claim 1 .

3. A compound according to claim 1 , characterized in that

R 1

being phenyl or pyridyl, any of which is substituted with one to three substituents X;

and with the option that each of phenyl or pyridyl in addition may be substituted by up to 3 radicals independently of one another selected from the group of C 1 -C 6 -alkyl, trifluoromethyl, or halogen,

R 2

being phenyl or pyridyl, where phenyl is substituted by 1 to 3 radicals and heteroaryl is optionally substituted by 1 to 3 radicals in each case independently of one another selected from the group of C 1 -C 6 -alkyl, C 1 -C 6 -alkoxy, trifluoromethyl, halogen and C 1 -C 6 -alkylthio,

where each of C 1 -C 6 -alkyl, C 1 -C 6 -alkoxy and C 1 -C 6 -alkylthio, are optionally substituted by one to three halogen radicals,

and the remaining characteristics as defined in claim 1 .

4. A compound according to claim 1 , characterized in that

R 1

is phenyl or pyridyl, any of which is substituted with 1 to 3 X, and wherein X is C 1 -C 6 -alkoxy, substituted by 2 to 6 halogen atoms, selected from the group of fluoro, chloro and bromo, whereby the C-atom which constitutes the beta position with respect to the link to the phenyl or pyridyl is substituted with at least one halogen;

and with the option that each of phenyl or pyridyl in addition may be substituted by up to 3 radicals independently of one another selected from the group of C 1 -C 6 -alkyl, trifluoromethyl, halogen,

and the remaining characteristics as defined in claim 1 .

5. A compound according to claim 1 , characterized in that for R 1 the substitution pattern at the one to 3 mandatory substituents X are at least 2 fluoro substituents, whereby the C-atom which constitutes the beta position with respect to the link to the phenyl or pyridyl is substituted with at least one halogen.

6. A compound according to claim 1 , characterized in that R 1 is 2-trifluoromethoxyphenyl.

7. A compound selected from the group consisting of

Com-

pound

No.

Structure

 1

 2

 3

 4

 5

 6

 7

 8

 9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

29

30

30-1

30-2

30-3

30-4

30-5

31

32

33

34

35

36

37

38

39

8. A pharmaceutically acceptable salt of a compound according to claim 1 .

9. A pharmaceutical composition comprising a compound according to claim 1 .

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 12, 2010
From: EICKMEIER, CHRISTIAN; DORNER-CIOSSEK, CORNELIA; FIEGEN, DENNIS; FOX, THOMAS; FUCHS, KLAUS; GIOVANNINI, RICCARDO; HEINE, NIKLAS; HENDRIX, MARTIN; ROSENBROCK, HOLGER; SCHAENZLE, GERHARD
To: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
Reel/Frame 025123/0875 →
Priority Claims (3)
EP 07425764 · Nov 30, 2007 · regional
EP 08163548 · Sep 3, 2008 · regional
EP 08169282 · Nov 17, 2008 · regional
Continuity (1)
Related Publication 20110015193A1 · Jan 20, 2011